These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24200350)

  • 1. [Interventional prevention of ischemic stroke].
    Kamtchueng P; Teiger E
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):411-8. PubMed ID: 24200350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
    Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
    Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous exclusion of the left atrial appendage: perspectives].
    Aubry P; Juliard JM; Brochet E; Himbert D; Vahanian A
    Ann Cardiol Angeiol (Paris); 2012 Dec; 61(6):423-31. PubMed ID: 23069013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
    Price MJ
    Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left atrial appendage closure and embolic events].
    Akodad M; Garot P
    Ann Cardiol Angeiol (Paris); 2017 Dec; 66(6):441-446. PubMed ID: 29106834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
    Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
    Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left atrial appendage occlusion: New perspectives for the method.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    Bajaj NS; Kalra R; Patel N; Hashim T; Godara H; Ather S; Arora G; Pasala T; Whitfield TT; McGiffin DC; Ahmed MI; Lloyd SG; Limdi NA; Arora P
    PLoS One; 2016; 11(10):e0163608. PubMed ID: 27706224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Waksman R; Pendyala LK
    Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage exclusion: state-of-the-art.
    Cruz-Gonzalez I; Yan BP; Lam YY
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure: a new technique for clinical practice.
    John Camm A; Colombo A; Corbucci G; Padeletti L
    Heart Rhythm; 2014 Mar; 11(3):514-21. PubMed ID: 24291776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.